Literature DB >> 11484704

Paroxetine for the prevention of depression induced by interferon alfa.

M R Kraus, A Schäfer, M Scheurlen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11484704

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  What the infectious disease physician needs to know about pegylated interferon and ribavirin.

Authors:  Naveen Gara; Marc G Ghany
Journal:  Clin Infect Dis       Date:  2013-02-21       Impact factor: 9.079

2.  Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C.

Authors:  Michael-R Kraus; Arne Schäfer; Herbert Csef; Michael Scheurlen
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

3.  Hepatitis C treatment of patients with bipolar disorder: a case series.

Authors:  Muhamad Aly Rifai
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

Review 4.  Pharmacological management of depression in patients with cancer: practical considerations.

Authors:  Riccardo G V Torta; Valentina Ieraci
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

Review 5.  Neuropsychiatric side effects of interferon-alfa therapy.

Authors:  Arthur R Van Gool; Wim H J Kruit; Frederike K Engels; Gerrit Stoter; Marjolein Bannink; Alexander M M Eggermont
Journal:  Pharm World Sci       Date:  2003-02

6.  Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Authors:  Benedikt Fischer; Emma Haydon; Jürgen Rehm; Mel Krajden; Jens Reimer
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

7.  [Hepatitis (Hep-Net) competence network].

Authors:  H Wedemeyer; S Meyer; M P Manns
Journal:  Internist (Berl)       Date:  2004-04       Impact factor: 0.743

Review 8.  Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review.

Authors:  Arne Schäfer; Hans-Ulrich Wittchen; Jochen Seufert; Michael R Kraus
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

9.  Major depression during interferon-alpha treatment: vulnerability and prevention.

Authors:  Francis E Lotrich
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

Review 10.  The role of neuroinflammation and neurovascular dysfunction in major depressive disorder.

Authors:  Sang Won Jeon; Yong-Ku Kim
Journal:  J Inflamm Res       Date:  2018-05-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.